Tara Callaghan

All articles by Tara Callaghan

RINVOQ® (upadacitinib) Has Remission Data, With or Without Methotrexate1-3

Over the past decade, the use of targeted therapies has become a staple in the management of rheumatoid arthritis (RA) and other autoimmune disorders.4,5 One class of targeted therapies approved for moderate to severe RA is the Janus kinase (JAK) inhibitors.6 JAK inhibitors are small-molecule therapies that target the signal transducer and activator of transcription…